A workshop at the upcoming MichBio conference will walk biotech companies through the maze of government, quasi-government, and private funding options so technology leaders can generate needed capital and keep their companies’ growth on track.
According to excerpts from the story:
MichBio, the state’s life sciences trade association, will be hosting a workshop on April 22 to look at how biotechnology companies can select the best funding sources. The workshop is scheduled in the afternoon just before the MichBio annual meeting.
The workshop is called Capital Formation: Lost in Translation. Industry experts will demystify the benefits, processes and lingo involved in raising money from non-dilutive funding like SBIR and STTR programs, debt sources such as the Michigan Economic Development Corp., and equity sources such as venture capital and corporate investment.
Read the complete story here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.